(0.01%) 5 517.50 points
(0.13%) 39 895 points
(0.04%) 19 758 points
(-0.04%) $81.60
(0.43%) $2.82
(-0.26%) $2 338.40
(0.14%) $29.57
(0.55%) $1 007.30
(0.11%) $0.932
(-0.08%) $10.53
(0.01%) $0.788
(-0.85%) $87.25
0.00% $ 0.0151
Live Chart Being Loaded With Signals
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer...
Stats | |
---|---|
Dzisiejszy wolumen | 7 022 |
Średni wolumen | 0 |
Kapitalizacja rynkowa | 11.58M |
EPS | $-0.0844 ( Q1 | 2024-05-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-10 | Cogley Brian | Buy | 5 000 | Common Stock |
2024-01-10 | Cogley Brian | Sell | 0 | Common Stock |
2024-01-12 | Desilva Tara | Buy | 1 800 | Common Stock |
2024-01-12 | Desilva Tara | Buy | 466 | Common Stock |
2024-01-05 | Yerace Daniel Alexander | Buy | 10 850 | Common Stock |
INSIDER POWER |
---|
-74.77 |
Last 21 transactions |
Buy: 105 996 | Sell: 1 403 923 |
Coeptis Therapeutics Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Coeptis Therapeutics Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-1.00M (0.00 %) |
EPS: | $-0.830 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-1.00M (0.00 %) |
EPS: | $-0.830 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-1.00M (0.00 %) |
EPS: | $-2.87 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Coeptis Therapeutics
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and CD38-Diagnostic, an in vitro screening tool to provide the ability to pre-determine which cancer patients are most likely to benefit from targeted anti-CD38 monoclonal antibodies therapies. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn\'s disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson\'s Disease. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej